Shares of hVIVO plc (LON:HVO – Get Free Report) traded down 6.8% during mid-day trading on Friday . The company traded as low as GBX 19 ($0.24) and last traded at GBX 19.10 ($0.24). 2,518,262 shares were traded during trading, a decline of 26% from the average session volume of 3,389,765 shares. The stock had previously closed at GBX 20.50 ($0.25).
hVIVO Price Performance
The business has a 50-day moving average of GBX 23.20 and a 200 day moving average of GBX 26.66. The firm has a market capitalization of £129.95 million, a P/E ratio of 636.67 and a beta of 0.97. The company has a current ratio of 1.61, a quick ratio of 1.16 and a debt-to-equity ratio of 33.86.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Recommended Stories
- Five stocks we like better than hVIVO
- What is the Nikkei 225 index?
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- The 3 Best Blue-Chip Stocks to Buy Now
- Nebius Group: The Rising Star in AI Infrastructure
- EV Stocks and How to Profit from Them
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
